Pune, India, April 06, 2022 (GLOBE NEWSWIRE) -- According to MarketStudyReport, global liquid biopsy market size is expected to grow at a CAGR of over 29.7% between 2021 and 2027, driven by rising consumer preference for non-invasive diagnostic methods across the world.
Proceeding further, the research literature splits the market based on biomarkers, product type, and application scope. It also covers both qualitative and quantitative aspects of major segments to impart a pervasive understanding of the industry dynamics. Besides, a record of competitive hierarchy and evaluation of product ranges provided by leading players are also presented in the study.
Moreover, factors such as ongoing advancements in cancer diagnostic technologies, increasing incidence of cancer, and growing awareness about early diagnosis are likely to propel industry growth in the upcoming years.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/4547857/
For the uninitiated, liquid biopsy is a blood test that checks for any cancer cells in tumors circulating in the blood or DNA remains from tumor cells present in the blood. The treatment has been proven to be effective in early stage detection of cancer and is also used to help curate treatment plans, track effectivity, and determine if the cancer has recurred.
Despite the positive outlook, dearth of skilled professionals, and strict regulatory frameworks in several regions are expected to restrict market remuneration scope in the upcoming years.
Market segmentation review:
Based on application scope, the industry is classified into colorectal cancer, breast cancer, lung cancer, and prostate cancer. Prostate cancer segment captured 9% revenue share in worldwide liquid biopsy industry in 2020 and is slated to grow at a healthy CAGR over 2021-2027. This can be attributed to higher disease prevalence in emerging countries, which has intensified the adoption of advanced diagnostic technologies.
Considering product type, the industry has been classified into kits & reagents, assay & panels, and others. Of these, the others segment is expected to bolster significantly over the forecast period, on the back of increasing focus towards developing specific instruments to manage workflow and ease complex procedures.
Moving on to biomarker type, the business vertical has been classified into circulating tumor cells (CTC), circulating tumor DNA, and others. The circulating tumor cells segment is expected to record a CAGR of 29.7% over the review timeline, driven by high specificity of this biomarker. Additionally, high risk of metastatic conditions, and increasing manufacturer efforts to boost accessibility are anticipated to enhance segmental outlook in the upcoming years.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/liquid-biopsy-market
Regional outlook overview:
On the regional front, Latin America liquid biopsy market size is touted to register 29.4% CAGR over the analysis timeframe. This can be ascribed to increased emphasis among companies on organizational expansion to boost product accessibility throughout the region.
Global Liquid Biopsy Market, by Biomarkers (Revenue, USD Million, 2016-2027)
- Circulating Tumor Cells (CTC)
- Circulating Tumor DNA (ctDNA)
Global Liquid Biopsy Market, by Product Type (Revenue, USD Million, 2016-2027)
- Kits & Reagents
- Assay & Panels
- Others
Global Liquid Biopsy Market, by Application Scope (Revenue, USD Million, 2016-2027)
- Colorectal cancer
- Breast Cancer
- Lung Cancer
- Prostate Cancer
Global Liquid Biopsy Market, by Regional Outlook (Revenue, USD Million, 2016-2027)
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Italy
- Germany
- Spain
Asia Pacific
- China
- Japan
- India
Latin America
- Mexico
- Brazil
Middle East & Africa
- South Africa
- Saudi Arabia
Rest of the World
Global Liquid Biopsy Market, Competitive Dashboard (Revenue, USD Million, 2016-2027)
- Menarini Silicon Biosystems
- Bio-Rad Laboratories Inc.
- MDxHealth S.A.
- Freenome Holdings Inc.
- Lucene Health Inc.
- Epigenomics AG
- Oncimmune
- ANGLE plc
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Guardant Health Inc.
- Myriad Genetics Inc.
- BIOCEPT Inc.
- QIAGEN N.V.
Table of Content:
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East and Africa
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Liquid biopsy industry 360 degree synopsis, 2016 - 2027 (USD Million)
2.1.1 Business trends
2.1.2 Biomarkers trends
2.1.3 Product trends
2.1.4 Application trends
2.1.5 Regional trends
Chapter 3 Liquid Biopsy Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2016 - 2027 (USD Million)
3.3 Industry impact forces
3.4 Growth potential analysis
3.4.1 By biomarkers
3.4.2 By product
3.4.3 By application
3.5 COVID-19 impact analysis
3.6 Service provider landscape
3.7 Porter's analysis
3.8 Competitive landscape, 2020
3.9 PESTEL analysis
Chapter 4 Liquid Biopsy Market, By Biomarkers
4.1 Key segment trends
4.2 Circulating tumor cells (CTC)
4.2.1 Market size, by region, 2016 - 2027 (USD Million)
4.3 Circulating tumor DNA (ctDNA)
4.3.1 Market size, by region, 2016 - 2027 (USD Million)
4.4 Others
4.4.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 5 Liquid Biopsy Market, By Product
5.1 Key segment trends
5.2 Kits & reagents
5.2.1 Market size, by region, 2016 - 2027 (USD Million)
5.3 Assay & panels
5.3.1 Market size, by region, 2016 - 2027 (USD Million)
5.4 Others
5.4.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 6 Liquid Biopsy Market, By Application
6.1 Key segment trends
6.2 Lung cancer
6.2.1 Market size, by region, 2016 - 2027 (USD Million)
6.3 Breast cancer
6.3.1 Market size, by region, 2016 - 2027 (USD Million)
6.4 Colorectal cancer
6.4.1 Market size, by region, 2016 - 2027 (USD Million)
6.5 Prostate cancer
6.5.1 Market size, by region, 2016 - 2027 (USD Million)
6.6 Others
6.6.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 7 Liquid Biopsy Market, By Region
Related Report:
Biopsy Devices Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 - 2027
The biopsy devices market is expected to witness notable growth by 2027 owing to surging demand for diagnostics and high prevalence of diseases across the globe. Additionally, manufacturers are integrating advanced technologies into devices for efficient biopsies and better clinical outcomes, which is projected to further fuel market demand over the forecast period. The COVID-19 outbreak disrupted cancer care worldwide by causing a delay in diagnoses and treatment as well as by bringing clinical trials to a halt. Therefore, the healthcare industry took measures to ensure the reorganization of cancer services so that patients could continue to obtain essential care and treatment. On the regional spectrum, the Middle East & Africa biopsy devices market is anticipated to see moderate growth by 2027, expanding at a steady pace through the forecast period. Escalating focus on improving procedure accessibility and rising need for facility expansion to cater to the proliferating disease prevalence across MEA are expected to foster regional market outlook in the future.
About US:
Market Study Report is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.
